Biotech May Be the Next U.S.-China Battleground
Investors in Chinese biotech—and perhaps their U.S. clients too—should be prepared for a rough ride.
Meiji Holdings Co., Ltd., through its subsidiaries, engages in the manufacture and sale of dairy products, confectioneries, nutritional products, and pharmaceuticals in Japan and internationally. The company operates through two segments, Food and Pharmaceutical. It provides yogurt, cheese, drinking milk, beverages, butter, margarine, cream, ice cream, frozen food, chocolates, gummy, chewing gums, sports nutrition products, protein, infant formula, enteral formula, beauty supplements, OTC drugs, feed stuffs, sugar, and corn sweeteners. The company also offers ethical pharmaceutical products, including drugs for infectious and CNC disorders, vaccines, blood plasma products, generic drugs, and animal health products. Meiji Holdings Co., Ltd. was founded in 1916 and is headquartered in Tokyo, Japan.
20.6 | |
20.6 | |
- | |
20.6 | |
20.6 | |
19.1-23.2 | |
5 817 M | |
17.913 | |
271 M | |
1 121 464 M | |
0.0294 | |
-0.035 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: